Genotype-phenotype correlation of CYP2C19: phenoconversion, population-specific characteristics, and modern sequencing approaches in personalised pharmacotherapy
Klinická farmakologie a farmacie · 14.10.2026 · 40 (3) · 176-180
DOI: 10.36290/far.2026.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 14.10.2026. Verfasst von Jan Soukop und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Soukop, J., Pecha, M., & Anzenbacher, P. (2026). Genotype-phenotype correlation of CYP2C19: phenoconversion, population-specific characteristics, and modern sequencing approaches in personalised pharmacotherapy. Klinická farmakologie a farmacie, 40(3), 176-180. https://doi.org/10.36290/far.2026.027
Vancouver
Soukop J, Pecha M, Anzenbacher P. Genotype-phenotype correlation of CYP2C19: phenoconversion, population-specific characteristics, and modern sequencing approaches in personalised pharmacotherapy. Klinická farmakologie a farmacie. 2026;40(3):176-180. doi:10.36290/far.2026.027
BibTeX
@article{Soukop2026,
author = {Soukop, Jan and Pecha, Marek and Anzenbacher, Pavel},
title = {Genotype-phenotype correlation of CYP2C19: phenoconversion, population-specific characteristics, and modern sequencing approaches in personalised pharmacotherapy},
journal = {Klinická farmakologie a farmacie},
year = {2026},
volume = {40},
number = {3},
pages = {176--180},
doi = {10.36290/far.2026.027}
}
EUVIMED